Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate the dose response, and efficacy of Mapracorat ophthalmic formulation compared to its vehicle for the prevention of symptoms and signs associated with allergi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bausch & Lomb Incorporated
NCT07385495 · Conjunctivitis, Allergic
NCT06063044 · Rhinitis, Allergic, Asthma, Allergic, and more
NCT03375775 · Rhinitis, Allergic, Conjunctivitis, Allergic, and more
NCT04071249 · Rhinoconjunctivitis, Allergic
NCT03758456 · Rhinitis, Allergic, Rhinoconjunctivitis, Allergic
Bausch & Lomb
Rochester, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions